iohexol has been researched along with Bladder Cancer in 13 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fifty-four lung neoplasms in 31 patients were treated with RF ablation." | 2.71 | Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. ( Akeboshi, M; Hataji, O; Nakatsuka, A; Taguchi, O; Takao, M; Takeda, K; Yamakado, K, 2004) |
| "There were five upper tract and 33 bladder tumors with overall prevalence of 1." | 1.46 | Split-bolus CT urogram: Is less more? ( Newhouse, JH; Shaish, H, 2017) |
| "The detection of bladder cancer on low-dose scans with AIDR 3D is almost equal to that on routine-dose scans with FBP on the EP, with nearly 70% dose reduction." | 1.43 | Detection of bladder cancer: comparison of low-dose scans with AIDR 3D and routine-dose scans with FBP on the excretory phase in CT urography. ( Azuma, H; Inada, Y; Juri, H; Koyama, M; Kumano, S; Narumi, Y; Tsuboyama, T, 2016) |
| "Fifty patients diagnosed with bladder cancer were examined during the unenhanced (UP), corticomedullary (CMP), and excretory phases (EP)." | 1.40 | Contrast enhancement in bladder tumors examined with CT urography using traditional scan phases. ( Dahlman, P; Helenius, M; Lönnemark, M; Magnusson, A; Magnusson, M, 2014) |
| "Visceral metastases (16/105, 15." | 1.39 | Surveillance of patients with bladder cancer following cystectomy: yield of CT urography. ( Sadow, CA; Shinagare, AB; Silverman, SG, 2013) |
| "In staging bladder cancer, MRI, (11)C-acetate PET/CT and CT displayed similar levels of accuracy." | 1.38 | Prospective evaluation of MRI, ¹¹C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer. ( Akin, O; Bochner, BH; Dalbagni, G; Hricak, H; Olgac, S; Schöder, H; Vargas, HA, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shinagare, AB | 1 |
| Sadow, CA | 2 |
| Silverman, SG | 2 |
| Helenius, M | 1 |
| Dahlman, P | 1 |
| Magnusson, M | 1 |
| Lönnemark, M | 1 |
| Magnusson, A | 1 |
| Hansen, C | 1 |
| Becker, CD | 1 |
| Montet, X | 1 |
| Botsikas, D | 1 |
| Juri, H | 1 |
| Tsuboyama, T | 1 |
| Kumano, S | 1 |
| Inada, Y | 1 |
| Koyama, M | 1 |
| Azuma, H | 1 |
| Narumi, Y | 1 |
| Zhang, GM | 1 |
| Sun, H | 1 |
| Shi, B | 1 |
| Jin, ZY | 1 |
| Xue, HD | 1 |
| Shaish, H | 1 |
| Newhouse, JH | 1 |
| Wheeler, SC | 1 |
| Kim, J | 1 |
| Ohno-Machado, L | 1 |
| Takeuchi, M | 1 |
| Kawai, T | 1 |
| Ito, M | 1 |
| Ogawa, M | 1 |
| Ohashi, K | 1 |
| Hara, M | 1 |
| Shibamoto, Y | 1 |
| Vargas, HA | 1 |
| Akin, O | 1 |
| Schöder, H | 1 |
| Olgac, S | 1 |
| Dalbagni, G | 1 |
| Hricak, H | 1 |
| Bochner, BH | 1 |
| Akeboshi, M | 1 |
| Yamakado, K | 1 |
| Nakatsuka, A | 1 |
| Hataji, O | 1 |
| Taguchi, O | 1 |
| Takao, M | 1 |
| Takeda, K | 1 |
| Purcell, DD | 1 |
| Coakley, FV | 1 |
| Franc, BL | 1 |
| Hawkins, RA | 1 |
| Boddington, SE | 1 |
| Yeh, BM | 1 |
| Chow, LC | 1 |
| Kwan, SW | 1 |
| Olcott, EW | 1 |
| Sommer, G | 1 |
| Voegeli, E | 1 |
| Woessmer, B | 1 |
2 trials available for iohexol and Bladder Cancer
| Article | Year |
|---|---|
Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response.
Topics: Aged; Carcinoma; Catheter Ablation; Contrast Media; Digestive System Neoplasms; Feasibility Studies; | 2004 |
[Evaluation of clinical tolerability and diagnostic efficacy of ioversol 350 in UIV. A randomized double-blind study of ioversol 350 versus iohexol 350].
Topics: Double-Blind Method; Female; Hematuria; Humans; Injections, Intravenous; Iohexol; Male; Middle Aged; | 1992 |
11 other studies available for iohexol and Bladder Cancer
| Article | Year |
|---|---|
Surveillance of patients with bladder cancer following cystectomy: yield of CT urography.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Cystectomy; Female; Humans; Iohexol; Male; Middle Ag | 2013 |
Contrast enhancement in bladder tumors examined with CT urography using traditional scan phases.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Humans; Iohexol; Male; Middle Aged; Tomograp | 2014 |
Diagnosis of urothelial tumors with a dedicated dual-source dual-energy MDCT protocol: preliminary results.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Female; Humans; Iohexol; Ma | 2014 |
Detection of bladder cancer: comparison of low-dose scans with AIDR 3D and routine-dose scans with FBP on the excretory phase in CT urography.
Topics: Aged; Aged, 80 and over; Contrast Media; Female; Humans; Imaging, Three-Dimensional; Iohexol; Male; | 2016 |
Quantitative CT texture analysis for evaluating histologic grade of urothelial carcinoma.
Topics: Aged; Biopsy; Contrast Media; Feasibility Studies; Female; Humans; Iohexol; Male; Middle Aged; Neopl | 2017 |
Split-bolus CT urogram: Is less more?
Topics: Aged; Carcinoma, Transitional Cell; Contrast Media; Cystoscopy; Female; Humans; Iohexol; Male; Predi | 2017 |
Positive predictive value of CT urography in the evaluation of upper tract urothelial cancer.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Humans; Iohexol; Logistic Models; Male; Midd | 2010 |
Split-bolus CT-urography using dual-energy CT: feasibility, image quality and dose reduction.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Feasibility Studies; Female; Humans; Iohexol; Male; | 2012 |
Prospective evaluation of MRI, ¹¹C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer.
Topics: Acetates; Adult; Aged; Carbon; Contrast Media; Female; Humans; Iohexol; Magnetic Resonance Imaging; | 2012 |
Anterior layering of excreted 18F-FDG in the bladder on PET/CT: frequency and cause.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; | 2007 |
Split-bolus MDCT urography with synchronous nephrographic and excretory phase enhancement.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Humans; Iohexol; Male; Predictive Value of T | 2007 |